Predictors of neurocognitive impairment at 3years after a first episode non-affective psychosis

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 43, Issue , 2013, Pages 23-28

  Ayesa Arriola, Rosa ^a,b   Pérez Iglesias, Rocío ^a,b,c   Rodríguez Sánchez, José Manuel ^a,b   Pardo García, Gema ^a   Tabares Seisdedos, Rafael ^b,d   Ayuso Mateos, Jose L ^b,e   Vázquez Barquero, Jose L ^a,b   Crespo Facorro, Benedicto ^a,b  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF VALENCIA   (Spain)

^e UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

First episode psychosis; Neurocognition; Schizophrenia

Indexed keywords

ARIPIPRAZOLE; HALOPERIDOL; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

ADOLESCENT; ADULT; ARTICLE; BRIEF PSYCHOTIC DISORDER; CLINICAL DECISION MAKING; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; DEMOGRAPHY; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; INTELLIGENCE QUOTIENT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; MORBIDITY; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TEST; PATIENT CODING; PREDICTOR VARIABLE; PSYCHOSIS; RISK ASSESSMENT; RISK FACTOR; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIFORM DISORDER; TREATMENT PLANNING; VERBAL MEMORY;

ADOLESCENT; ADULT; COGNITION DISORDERS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTELLIGENCE TESTS; LONGITUDINAL STUDIES; MALE; MEMORY; MIDDLE AGED; MOTOR SKILLS; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; REGRESSION ANALYSIS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIOECONOMIC FACTORS; TRAIL MAKING TEST; WECHSLER SCALES; YOUNG ADULT;

EID: 84871783542     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2012.11.012     Document Type: Article

References (50)

1. Addington D., Addington J., Maticka-Tyndale E., Joyce J. Reliability and validity of a depression rating scale for schizophrenics. Schizophr Res 1992, 6(3):201-208.
2. Andreasen N.C. Scale for the assessment of negative symptoms (SANS) 1983, University of Iowa.
3. Andreasen N.C. Scale for the assessment of positive symptoms (SAPS) 1984, University of Iowa.
4. Becker H.E., Nieman D.H., Wiltink S., Dingemans P.M., van de Fliert J.R., Velthorst E., et al. Neurocognitive functioning before and after the first psychotic episode: does psychosis result in cognitive deterioration?. Psychol Med 2010, 40(10):1599-1606.
5. Bilder R.M., Goldman R.S., Robinson D., Reiter G., Bell L., Bates J.A., et al. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am J Psychiatry 2000, 157(4):549-559.
6. Bora E., Yucel M., Pantelis C. Cognitive impairment in schizophrenia and affective psychoses: implications for DSM-V criteria and beyond. Schizophr Bull 2010, 36(1):36-42.
7. Cannon M., Caspi A., Moffitt T.E., Harrington H., Taylor A., Murray R.M., et al. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry 2002, 59(5):449-456.
8. Cannon-Spoor H.E., Potkin S.G., Wyatt R.J. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull 1982, 8(3):470-484.
9. Cegalis J., Bowlin J. Vigil: Software for the Assessment of Attention 1991, Forthought, Nashua, NH.
10. Cohen A.S., Saperstein A.M., Gold J.M., Kirkpatrick B., Carpenter W.T., Buchanan R.W. Neuropsychology of the deficit syndrome: new data and meta-analysis of findings to date. Schizophr Bull 2007, 33(5):1201-1212.
11. Cosway R., Byrne M., Clafferty R., Hodges A., Grant E., Abukmeil S.S., et al. Neuropsychological change in young people at high risk for schizophrenia: results from the first two neuropsychological assessments of the Edinburgh High Risk Study. Psychol Med 2000, 30(5):1111-1121.
12. Crespo-Facorro B., Perez-Iglesias R., Ramirez-Bonilla M., Martinez-Garcia O., Llorca J., Luis Vazquez-Barquero J. A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis. J Clin Psychiatry 2006, 67(10):1511-1521.
13. Crespo-Facorro B., Rodriguez-Sanchez J.M., Perez-Iglesias R., Mata I., Ayesa R., Ramirez-Bonilla M., et al. Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison. J Clin Psychiatry 2009, 70(5):717-729.
14. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV) 1996, American Psychiatric Press, Inc.
15. Gonzalez-Blanch C., Crespo-Facorro B., Alvarez-Jimenez M., Rodriguez-Sanchez J.M., Pelayo-Teran J.M., Perez-Iglesias R., et al. Cognitive dimensions in first-episode schizophrenia spectrum disorders. J Psychiatr Res 2007, 41(11):968-977.
16. Gonzalez-Blanch C., Crespo-Facorro B., Alvarez-Jimenez M., Rodriguez-Sanchez J.M., Pelayo-Teran J.M., Perez-Iglesias R., et al. Pretreatment predictors of cognitive deficits in early psychosis. Psychol Med 2008, 38(5):737-746.
17. Green M.F. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J Clin Psychiatry 2006, 67(Suppl. 9):3-8. (discussion 36-42).
18. Grube B.S., Bilder R.M., Goldman R.S. Meta-analysis of symptom factors in schizophrenia. Schizophr Res 1998, 31(2-3):113-120.
19. Gschwandtner U., Pfluger M., Aston J., Borgwardt S., Drewe M., Stieglitz R.D., et al. Fine motor function and neuropsychological deficits in individuals at risk for schizophrenia. Eur Arch Psychiatry Clin Neurosci 2006, 256(4):201-206.
20. Harris M.G., Henry L.P., Harrigan S.M., Purcell R., Schwartz O.S., Farrelly S.E., et al. The relationship between duration of untreated psychosis and outcome: an eight-year prospective study. Schizophr Res 2005, 79(1):85-93.
21. Heaton R.K., Gladsjo J.A., Palmer B.W., Kuck J., Marcotte T.D., Jeste D.V. Stability and course of neuropsychological deficits in schizophrenia. Arch Gen Psychiatry 2001, 58(1):24-32.
22. Heinrichs R.W., Zakzanis K.K. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998, 12(3):426-445.
23. Heinrichs R.W., Miles A.A., Smith D., Zargarian T., Vaz S.M., Goldberg J.O., et al. Cognitive, clinical, and functional characteristics of verbally superior schizophrenia patients. Neuropsychology 2008, 22(3):321-328.
24. Hoff A.L., Svetina C., Shields G., Stewart J., DeLisi L.E. Ten year longitudinal study of neuropsychological functioning subsequent to a first episode of schizophrenia. Schizophr Res 2005, 78(1):27-34.
25. Keefe R.S., Fenton W.S. How should DSM-V criteria for schizophrenia include cognitive impairment?. Schizophr Bull 2007, 33(4):912-920.
26. Khandaker G.M., Barnett J.H., White I.R., Jones P.B. A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophr Res 2011, 132(2-3):220-227.
27. Kurtz M.M., Wexler B.E., Fujimoto M., Shagan D.S., Seltzer J.C. Symptoms versus neurocognition as predictors of change in life skills in schizophrenia after outpatient rehabilitation. Schizophr Res 2008, 102(1-3):303-311.
28. Kurtz M.M., Jeffrey S.B., Rose J. Elementary neurocognitive function, learning potential and everyday life skills in schizophrenia: what is their relationship?. Schizophr Res 2010, 116(2-3):280-288.
29. Lehoux C., Everett J., Laplante L., Emond C., Trepanier J., Brassard A., et al. Fine motor dexterity is correlated to social functioning in schizophrenia. Schizophr Res 2003, 62(3):269-273.
30. Lezak, MD. Neuropsychological assessment. In O. U. Press, ed., 1995.
31. MacCabe J.H., Brebion G., Reichenberg A., Ganguly T., McKenna P.J., Murray R.M., et al. Superior intellectual ability in schizophrenia: neuropsychological characteristics. Neuropsychology 2012, 26(2):181-190.
32. Mañá S., Ivorra J., Girón M. Adaptación y fiabilidad de la entrevista para la evaluación de la discapacidad social en pacientes psiquiátricos (OMS). Rev Psiquiatr Fac Med Barc 1998, 25(2):43-48.
33. Middleton F.A., Strick P.L. Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain Res Brain Res Rev 2000, 31(2-3):236-250.
34. Osterrieth P.A. Contribution a l'étude de la perception et de la memoire (The test of copying a complex figure: a contribution to the study of perception and memory). Arch Psychol 1944, 30:286-350.
35. Palmer B.W., Heaton R.K., Paulsen J.S., Kuck J., Braff D., Harris M.J., et al. Is it possible to be schizophrenic yet neuropsychologically normal?. Neuropsychology 1997, 11(3):437-446.
36. Pelayo-Teran J.M., Perez-Iglesias R., Ramirez-Bonilla M.L., Gonzalez-Blanch C., Martinez-Garcia O., Pardo-Garcia G., et al. Epidemiological factors associated with treated incidence of first-episode non-affective psychosis in Cantabria: insights from the Clinical Programme on Early Phases of Psychosis. Early Interv Psychiatry 2008, 2(3):178-187.
37. Putnam K.M., Harvey P.D. Cognitive impairment and enduring negative symptoms: a comparative study of geriatric and nongeriatric schizophrenia patients. Schizophr Bull 2000, 26(4):867-878.
38. Reichenberg A., Weiser M., Rapp M.A., Rabinowitz J., Caspi A., Schmeidler J., et al. Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia. Arch Gen Psychiatry 2005, 62(12):1297-1304.
39. Reichenberg A., Harvey P.D., Bowie C.R., Mojtabai R., Rabinowitz J., Heaton R.K., et al. Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. Schizophr Bull 2009, 35(5):1022-1029.
40. Reitan R.M., Wolfson D. The Halstead-Reitan neuropsychological test battery: therapy and clinical interpretation 1985, Neuropsychological Press.
41. Rey A. L'examen clinique en psychologie 1964, Presses Universitaires de France.
42. Roy M.A., Lehoux C., Emond C., Laplante L., Bouchard R.H., Everett J., et al. A pilot neuropsychological study of Kraepelinian and non-Kraepelinian schizophrenia. Schizophr Res 2003, 62(1-2):155-163.
43. Schmidt S.J., Mueller D.R., Roder V. Social cognition as a mediator variable between neurocognition and functional outcome in schizophrenia: empirical review and new results by structural equation modeling. Schizophr Bull 2011, 37(Suppl. 2):S41-S54.
44. Sota T.L., Heinrichs R.W. Demographic, clinical, and neurocognitive predictors of quality of life in schizophrenia patients receiving conventional neuroleptics. Compr Psychiatry 2004, 45(5):415-421.
45. Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 2002, 8(3):448-460.
46. Toulopoulouand T., Murray R.M. Verbal memory deficit in patients with schizophrenia: an important future target for treatment. Expert Rev Neurother 2004, 4(1):43-52.
47. van Winkel R., Myin-Germeys I., De Hert M., Delespaul P., Peuskens J., van Os J. The association between cognition and functional outcome in first-episode patients with schizophrenia: mystery resolved?. Acta Psychiatr Scand 2007, 116(2):119-124.
48. Walker E.F., Lewine R.R., Neumann C. Childhood behavioral characteristics and adult brain morphology in schizophrenia. Schizophr Res 1996, 22(2):93-101.
49. Weschsler D. Weschsler Adult Intelligence Scale-III 1997, The Psychological Corporation.
50. Wilk C.M., Gold J.M., McMahon R.P., Humber K., Iannone V.N., Buchanan R.W. No, it is not possible to be schizophrenic yet neuropsychologically normal. Neuropsychology 2005, 19(6):778-786.